Prof. Ernst Rietzschel, MD, PhD is clinical cardiologist, working at Ghent University, Belgium, where he also holds a position as associate professor. His primary interest is in the field of prevention of cardiovascular diseases. His main scientific work for the past 16 years has been (and is) as primary investigator and leader of the ASKLEPIOS study.
This study is a successful cooperation of several research groups within Ghent University with expanding links to other European and international research groups. The study has been following a random population sample of 2524 subjects (aged on average 45 years in 2002) for more than 10 years.
One of the key strengths of the study is its breadth, encompassing both advances in Primary Care (the study was performed with the participation of 89 general practitioners), epi(genetics), advanced cardiac haemodynamical modeling and biomarker profiling. Ultimately, the long-term ASKLEPIOS goals are better risk prevention strategies, better understanding of cardiovascular function and of successful human aging.
Prof. Rietzschel is the recipient of a number scientific awards (among which the Young Investigator Award of the European Society of Cardiology and the Career Development Award from the international Artery Society). Author of >100 peer-reviewed papers (of which >75% in the top 25% impact Journals in the field), and member of the Lancet Commission on Hypertension.